X
NVCR icon

Xponance’s NovoCure NVCR Stock Holding History

Xponance’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,762
Closed -$231K – 1470
2024
Q4 		$231K Buy
+7,762
New +$164K ﹤0.01% 1238
2024
Q2 		– Sell
-13,623
Closed -$213K – 1353
2024
Q1 		$213K Sell
13,623
-352
-3% -$5.18K ﹤0.01% 1171
2023
Q4 		$209K Sell
13,975
-400
-3% -$5.35K ﹤0.01% 1147
2023
Q3 		$232K Buy
14,375
+8
+0.1% +$231 ﹤0.01% 1091
2023
Q2 		$596K Buy
14,367
+260
+2% +$16.1K 0.01% 834
2023
Q1 		$848K Buy
14,107
+105
+0.7% +$8.39K 0.01% 709
2022
Q4 		$1.03M Buy
14,002
+1,778
+15% +$134K 0.02% 630
2022
Q3 		$929K Buy
12,224
+202
+2% +$15.8K 0.02% 604
2022
Q2 		$836K Buy
12,022
+383
+3% +$28.9K 0.02% 632
2022
Q1 		$964K Buy
11,639
+133
+1% +$9.8K 0.02% 606
2021
Q4 		$864K Sell
11,506
-184
-2% -$18.5K 0.01% 667
2021
Q3 		$1.36M Sell
11,690
-274
-2% -$41.4K 0.03% 454
2021
Q2 		$2.65M Buy
11,964
+1,570
+15% +$305K 0.05% 301
2021
Q1 		$1.37M Sell
10,394
-94
-0.9% -$14.9K 0.03% 390
2020
Q4 		$1.81M Buy
10,488
+86
+0.8% +$11.8K 0.04% 329
2020
Q3 		$1.16M Sell
10,402
-37
-0.4% -$2.96K 0.03% 387
2020
Q2 		$619K Buy
+10,439
New +$687K 0.02% 509

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Xponance's NVCR Position: Q1 2025 in Review

Xponance sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 7,762 shares — an estimated $231K sold.

Xponance first reported a position in NVCR in Q2 2020 and held it in 17 quarters. The position peaked at $2.65M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • Xponance reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • Xponance sold 7,762 NovoCure shares in Q1 2025, an estimated $231K.
  • Xponance first reported a position in NovoCure in Q2 2020 and held it in 17 quarters.
  • Xponance's NovoCure position peaked at $2.65M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on Xponance's 13F filing for Q1 2025, filed 1 May 2025.